Explore 3 Stock Ideas & Industry Insights Download Free Report

Principal Technologies Inc

Company price
0.32 CAD 0.00(0%)
Last update at 2026-11-03T14:30:00Z
Market Cap
26.54M

Momentum Score

…

Principal Technologies Inc. is a private equity firm specializing in growth capital and middle market investments and direct equity investments. It invests in form of equity related and secured convertible debt. It invests in healthcare technology companies and assets. It seeks to identify technologies with IP capable of improving patient outcomes by enhancing medical treatment quality and efficiency, cost-efficiency, optimization of the patient pathway, and implementation of point of care technologies. The firm seeks to invest globally privately. Principal Technologies Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada and has additional office in Vienna, Austria.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.32
Low
0.32
High
52 Week Price Range
0.14
Low
0.71
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Principal Technologies Inc, listed under ticker PTEC.V, has limited publicly available disclosure and its core operations and product lines are not clearly described in public filings. Because of that scarcity of information, investors may find potential exposure to an early-stage issuer attractive if it achieves commercial traction, but specific long-term growth drivers are not confirmed by public sources.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.32
Dividend Yield
-
Revenue TTM
0.37M
Revenue Per Share
0.01
Gross Profit TTM
0.37M
Debt / Equity
-
ROE
-18588.49%
Net Debt
-
ROCE
-2084.39%
Diluted EPS TTM
-0.12

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Income before tax -4.20M -1.54M -1.02M -1.31M -0.44M
Minority interest -0.01M -0.04M -0.00M -0.00M -
Net income -4.24M -1.62M -1.03M -1.35M -0.44M
Selling general administrative 4.01M 1.99M 1.31M 1.66M 0.45M
Reconciled depreciation 0.05M 0.05M 0.03M 0.02M -
Ebit - - - - -0.39M
Ebitda - - - -1.28M -0.45M
Operating income -4.18M -1.51M -1.01M -1.34M -0.45M
Interest expense 0.02M 0.03M 0.01M 0.01M 0.00M
Tax provision 0.02M 0.03M 0.01M 0.04M -
Interest income 0.02M 0.02M 0.00M 0.00M 0.00M
Net interest income 0.00M -0.01M -0.01M -0.01M 0.00M
Total revenue 0.37M 0.66M 0.43M 0.34M 0.00M
Total operating expenses 4.55M 2.18M 1.43M 1.68M 0.45M
Total other income expense net -0.02M -0.02M -0.01M 0.04M -
Net income from continuing ops -4.22M -1.58M -1.03M -1.35M -0.44M
Net income applicable to common shares - - - - -0.44M
Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Total assets 1.55M 1.51M 0.73M 0.76M 1.44M
Total liab 1.36M 0.44M 0.53M 0.31M 0.07M
Total stockholder equity 0.09M 1.01M 0.15M 0.41M 1.36M
Other current liab 0.47M - - - 0.07M
Common stock - - - - 1.91M
Capital stock 7.14M 4.51M 2.50M 1.93M 1.91M
Retained earnings -8.94M -4.57M -2.95M -1.92M -0.57M
Other assets - - - - 0.15M
Cash 1.06M 0.85M 0.16M 0.35M 1.29M
Total current liabilities 1.35M 0.39M 0.48M 0.25M 0.07M
Short long term debt 0.14M - - - -
Other stockholder equity - - - - 0.03M
Total current assets 1.20M 1.13M 0.37M 0.43M 1.29M
Long term investments 0.26M 0.26M 0.26M 0.26M -
Net tangible assets - - - - 1.36M
Net receivables 0.04M 0.11M 0.12M 0.05M 0.00M
Accounts payable 0.70M - - - -
Non current assets total 0.34M 0.38M 0.35M 0.33M 0.15M
Capital lease obligations 0.05M 0.09M 0.08M 0.07M -
Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Investments - -0.07M -0.00M -0.26M -0.15M
Change to liabilities - - - - 0.07M
Total cashflows from investing activities - - - - -0.15M
Net borrowings 0.98M -0.02M - - -
Total cash from financing activities 3.24M 2.38M 0.26M -0.01M 0.19M
Change to operating activities - - - - -0.00M
Net income -4.24M -1.62M -1.03M -1.35M -0.44M
Change in cash 0.20M 0.70M -0.19M -0.94M -0.35M
Begin period cash flow 0.85M 0.16M 0.35M 1.29M 1.64M
End period cash flow 1.06M 0.85M 0.16M 0.35M 1.29M
Total cash from operating activities -3.03M -1.64M -0.47M -0.64M -0.38M
Issuance of capital stock 1.80M 2.43M 0.30M 0.00M 0.18M
Depreciation 0.05M 0.05M 0.03M 0.02M -
Other cashflows from investing activities - - - - -0.15M
Change to account receivables - - - - -0.00M
Capital expenditures 0.01M 0.07M 0.00M 0.00M 0.00M
Change in working capital 0.45M -0.16M 0.18M 0.29M 0.07M
Stock based compensation 0.65M 0.03M 0.35M 0.40M -
Other non cash items 0.00M 0.03M 0.01M 0.01M -
Free cash flow -3.04M -1.71M -0.47M -0.64M -0.38M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PTEC
Principal Technologies Inc
-
-%
0.32 - - 62.75 355.42 72.08 -0.81
NURS
Hydreight Technologies Inc
-0.04
1.32%
2.98 406.00 25.91 7.85 20.38 7.45 109.02
ADK
Diagnos Inc
-0.01
1.41%
0.35 - 10.00 411.24 18.74 389.06 -6.16
NXG
NexgenRX Inc.
-
-%
0.66 39.00 32.68 1.55 4.64 1.39 7.84
CHS
Comprehensive Healthcare Systems Inc
-
-%
0.33 - - 4.44 13.23 3.83 26.88

Profile*

Principal Technologies Inc

Principal Technologies Inc. is a private equity firm specializing in growth capital and middle market investments and direct equity investments. It invests in form of equity related and secured convertible debt. It invests in healthcare technology companies and assets. It seeks to identify technologies with IP capable of improving patient outcomes by enhancing medical treatment quality and efficiency, cost-efficiency, optimization of the patient pathway, and implementation of point of care technologies. The firm seeks to invest globally privately. Principal Technologies Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada and has additional office in Vienna, Austria.

700 W Georgia Street, Vancouver, BC, Canada, V6C 1H2

587 225 2599

Name Title Year Born
Mr. Gerald Trent Group CEO, Pres & Director 1977
Mr. Frank Stronach CFO, Corp. Sec. & Director 1951
Mr. Gerald Trent Group CEO, President & Director 1978
Mr. Peter L. A. McKeown C.A., CA CFO & Corporate Secretary NA
Ilse Christa Eder CEO of E&E CRO Consulting NA
Mr. Peter L. A. McKeown C.A. Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…